Nanotechnology: Towards Reducing Animal Testing
28-29 May 2008, The Royal Society, London
Two weeks to go - places still available!
Latest Press Release >>
Animal testing is costly and there is a great deal of research on finding
viable and effective alternatives (new methods that refine existing tests
by minimizing animal distress, reducing animal usage, or replacing whole
animal tests). Despite large reductions in animal testing since the early
1980s due to improved in vitro methods, levels remain high (over 3 million
procedures in 2006) and results cannot always be extrapolated to humans.
The application of nanotechnology is currently revolutionizing medicine and this two-day conference, the first of its kind in Europe, will examine the role nanotechnology could also play in improving or refining the development of alternatives to animal testing whilst maintaining safety. Themes will include:
- a review of some of the most promising human cell-based in vitro models
- novel lab-on-a-chip and bioreactor systems for screening, toxicology and targeting studies
- surface modification at the nanoscale to improve biosensors and in vitro test systems
- potential new strategies for applying nanotechnology to alternatives
- the role of the European Centre for the Validation of Alternative Methods (ECVAM)
The conference will be of particular interest to those involved in:
- pharmaceutical, medical device and cosmetic development and testing
- environmental and food testing
- organizations interested in the development of animal alternatives.